Literature DB >> 20640171

The Quantification of Glycosaminoglycans: A Comparison of HPLC, Carbazole, and Alcian Blue Methods.

Sarah B Frazier1, Kevin A Roodhouse, Dennis E Hourcade, Lijuan Zhang.   

Abstract

Glycosaminoglycans (GAGs) are linear polysaccharides that are found in the extracellular matrix and biological fluids of animals where they interact with hundreds of proteins and perform a variety of critical roles. There are five classes of animal GAGs: heparan sulfate (HS), chondroitin sulfate (CS), dermatan sulfate (DS), keratan sulfate (KS), and hyaluronan (HA). Many biological functions can be monitored directly by their impact on GAG quantity. Thus, simple, sensitive, and robust GAG quantification methods are needed for the development of biomarkers. We have systematically compared three available GAG quantification assays including an HPLC-based assay, a simplified Alcian Blue assay, and a miniaturized carbazole assay. The carbazole and Alcian Blue assays were reproducible and simple to perform in general lab settings, but had important limitations: The carbazole assay could not detect KS and it overestimated GAGs that were contaminated with salts or dissolved in PBS. The Alcian Blue assay detected only those GAGs that were sulfated. In contrast, while the HPLC method was time-consuming, it was a robust and sensitive assay that not only detected all GAGs but also quantified glucosamine-GAGs and galactosamine-GAGs simultaneously. The HPLC assay was not affected by salt or level of GAG sulfation and it yielded reproducible values for all types of GAGs tested. These results suggest that an automated HPLC assay would be generally useful for the routine measurement of a panel of GAG-based biomarkers while the carbazole assay and the Alcian Blue assays could prove valuable for more specific purposes.

Entities:  

Year:  2008        PMID: 20640171      PMCID: PMC2904615          DOI: 10.2174/1875398100801010031

Source DB:  PubMed          Journal:  Open Glycosci


  37 in total

1.  Quantitation of proteoglycans in biological fluids using Alcian blue.

Authors:  M Karlsson; S Björnsson
Journal:  Methods Mol Biol       Date:  2001

Review 2.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 3.  Electrophoretic approaches to the analysis of complex polysaccharides.

Authors:  Nicola Volpi; Francesca Maccari
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-03-10       Impact factor: 3.205

Review 4.  Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans.

Authors:  Nissi M Varki; Ajit Varki
Journal:  Semin Thromb Hemost       Date:  2002-02       Impact factor: 4.180

5.  Melanoma cell-derived factor stimulation of fibroblast glycosaminoglycan synthesis--the role of platelet-derived growth factor.

Authors:  J L Godden; M Edward; R M MacKie
Journal:  Eur J Cancer       Date:  1999-03       Impact factor: 9.162

6.  Quantitation of proteoglycans as glycosaminoglycans in biological fluids using an alcian blue dot blot analysis.

Authors:  S Björnsson
Journal:  Anal Biochem       Date:  1998-02-15       Impact factor: 3.365

7.  Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins.

Authors:  Lianchun Wang; Jillian R Brown; Ajit Varki; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 8.  Treatment of interstitial cystitis.

Authors:  Michael B Chancellor; Naoki Yoshimura
Journal:  Urology       Date:  2004-03       Impact factor: 2.649

9.  Transforming growth factor beta1-regulated xylosyltransferase I activity in human cardiac fibroblasts and its impact for myocardial remodeling.

Authors:  Christian Prante; Hendrik Milting; Astrid Kassner; Martin Farr; Michael Ambrosius; Sylvia Schön; Daniela G Seidler; Aly El Banayosy; Reiner Körfer; Joachim Kuhn; Knut Kleesiek; Christian Götting
Journal:  J Biol Chem       Date:  2007-07-16       Impact factor: 5.157

10.  Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue.

Authors:  S Björnsson
Journal:  Anal Biochem       Date:  1993-05-01       Impact factor: 3.365

View more
  24 in total

1.  Oversulfated chondroitin sulfate is not the sole contaminant in heparin.

Authors:  Jing Pan; Yi Qian; Xiaodong Zhou; Andrew Pazandak; Sarah B Frazier; Peter Weiser; Hong Lu; Lijuan Zhang
Journal:  Nat Biotechnol       Date:  2010-03       Impact factor: 54.908

2.  Primary human chondrocyte extracellular matrix formation and phenotype maintenance using RGD-derivatized PEGDM hydrogels possessing a continuous Young's modulus gradient.

Authors:  Laura A Smith Callahan; Anna M Ganios; Erin P Childers; Scott D Weiner; Matthew L Becker
Journal:  Acta Biomater       Date:  2013-01-02       Impact factor: 8.947

Review 3.  Glycosaminoglycans detection methods: Applications of mass spectrometry.

Authors:  Francyne Kubaski; Harumi Osago; Robert W Mason; Seiji Yamaguchi; Hironori Kobayashi; Mikako Tsuchiya; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2016-09-28       Impact factor: 4.797

4.  Fact versus artifact: avoiding erroneous estimates of sulfated glycosaminoglycan content using the dimethylmethylene blue colorimetric assay for tissue-engineered constructs.

Authors:  C H Zheng; M E Levenston
Journal:  Eur Cell Mater       Date:  2015-04-19       Impact factor: 3.942

5.  Bioprinting 101: Design, Fabrication, and Evaluation of Cell-Laden 3D Bioprinted Scaffolds.

Authors:  Kaivalya A Deo; Kanwar Abhay Singh; Charles W Peak; Daniel L Alge; Akhilesh K Gaharwar
Journal:  Tissue Eng Part A       Date:  2020-03       Impact factor: 3.845

6.  Development and characterization of a naturally derived lung extracellular matrix hydrogel.

Authors:  Robert A Pouliot; Patrick A Link; Nabil S Mikhaiel; Matthew B Schneck; Michael S Valentine; Franck J Kamga Gninzeko; Joseph A Herbert; Masahiro Sakagami; Rebecca L Heise
Journal:  J Biomed Mater Res A       Date:  2016-04-06       Impact factor: 4.396

7.  Creation of disease-inspired biomaterial environments to mimic pathological events in early calcific aortic valve disease.

Authors:  Ana M Porras; Jennifer A Westlund; Austin D Evans; Kristyn S Masters
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-27       Impact factor: 11.205

8.  Identification of Chemically Sulfated/desulfated Glycosaminoglycans in Contaminated Heparins and Development of a Simple Assay for the Detection of Most Contaminants in Heparin.

Authors:  Jing Pan; Yi Qian; Xiaodong Zhou; Andrew Pazandak; Sarah B Frazier; Peter Weiser; Hong Lu; Lijuan Zhang
Journal:  Glycobiol Insights       Date:  2010-02-02

9.  Maximizing phenotype constraint and extracellular matrix production in primary human chondrocytes using arginine-glycine-aspartate concentration gradient hydrogels.

Authors:  Laura A Smith Callahan; Erin P Childers; Sharon L Bernard; Scott D Weiner; Matthew L Becker
Journal:  Acta Biomater       Date:  2013-04-06       Impact factor: 8.947

10.  Primary human colonic mucosal barrier crosstalk with super oxygen-sensitive Faecalibacterium prausnitzii in continuous culture.

Authors:  Jianbo Zhang; Yu-Ja Huang; Jun Young Yoon; John Kemmitt; Charles Wright; Kirsten Schneider; Pierre Sphabmixay; Victor Hernandez-Gordillo; Steven J Holcomb; Brij Bhushan; Gar Rohatgi; Kyle Benton; David Carpenter; Jemila C Kester; George Eng; David T Breault; Omer Yilmaz; Mao Taketani; Christopher A Voigt; Rebecca L Carrier; David L Trumper; Linda G Griffith
Journal:  Med (N Y)       Date:  2020-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.